- Home
- IT vs TEVA Comparison
IT vs TEVA Comparison
Compare IT & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IT
- TEVA
- Stock Information
- Founded
- IT 1979
- TEVA 1901
- Country
- IT United States
- TEVA Israel
- Employees
- IT N/A
- TEVA N/A
- Industry
- IT Other Consumer Services
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- IT Consumer Discretionary
- TEVA Health Care
- Exchange
- IT Nasdaq
- TEVA Nasdaq
- Market Cap
- IT 17.9B
- TEVA 21.2B
- IPO Year
- IT 1993
- TEVA N/A
- Fundamental
- Price
- IT $250.78
- TEVA $18.96
- Analyst Decision
- IT Hold
- TEVA Strong Buy
- Analyst Count
- IT 10
- TEVA 7
- Target Price
- IT $327.33
- TEVA $25.57
- AVG Volume (30 Days)
- IT 1.2M
- TEVA 9.0M
- Earning Date
- IT 11-04-2025
- TEVA 11-05-2025
- Dividend Yield
- IT N/A
- TEVA N/A
- EPS Growth
- IT 54.75
- TEVA N/A
- EPS
- IT 16.25
- TEVA N/A
- Revenue
- IT $6,420,009,000.00
- TEVA $16,628,000,000.00
- Revenue This Year
- IT $6.63
- TEVA $4.37
- Revenue Next Year
- IT $4.19
- TEVA $0.67
- P/E Ratio
- IT $15.40
- TEVA N/A
- Revenue Growth
- IT 5.89
- TEVA 2.08
- 52 Week Low
- IT $223.65
- TEVA $12.47
- 52 Week High
- IT $584.01
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- IT 50.50
- TEVA 43.30
- Support Level
- IT $246.66
- TEVA $18.83
- Resistance Level
- IT $261.10
- TEVA $20.10
- Average True Range (ATR)
- IT 8.20
- TEVA 0.45
- MACD
- IT 1.33
- TEVA -0.17
- Stochastic Oscillator
- IT 61.92
- TEVA 6.90
About IT Gartner Inc.
Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.